NCT01262235 2019-01-16A Dose Finding Study of TKM-080301 Infusion in Neuroendocrine Tumors (NET) and Adrenocortical Carcinoma (ACC) PatientsArbutus Biopharma CorporationPhase 1/2 Completed68 enrolled